Outcomes of surgical resection for primary duodenal adenocarcinoma: A systematic review.
Sign Up to like & getrecommendations! Published in 2019 at "Asian journal of surgery"
DOI: 10.1016/j.asjsur.2018.04.005
Abstract: Primary duodenal adenocarcinoma (PDAC) is a rare malignancy. The aim of this study was to evaluate the published evidence for resection with curative intent in patients with PDAC. A literature search was conducted in PubMed… read more here.
Keywords: surgical resection; outcomes surgical; primary duodenal; duodenal adenocarcinoma ... See more keywords
Clival Metastasis of a Duodenal Adenocarcinoma: A Case Report and Literature Review.
Sign Up to like & getrecommendations! Published in 2017 at "World neurosurgery"
DOI: 10.1016/j.wneu.2016.12.078
Abstract: BACKGROUND Clival metastases of adenocarcinomas are exceptionally rare tumors, especially when they arise from the small intestine. We present the first, to our knowledge, report of a metastasis of a duodenal adenocarcinoma to the clivus.… read more here.
Keywords: metastasis; metastasis duodenal; duodenal adenocarcinoma; clival metastasis ... See more keywords
Molecular alterations and PD-L1 expression in non-ampullary duodenal adenocarcinoma: Associations among clinicopathological, immunophenotypic and molecular features
Sign Up to like & getrecommendations! Published in 2019 at "Scientific Reports"
DOI: 10.1038/s41598-019-46167-y
Abstract: Non-ampullary duodenal adenocarcinoma (NADC) is extremely rare. Little is known about its clinicopathological and molecular features or its management. Herein we retrospectively analyzed the cases of 32 NADC patients, focusing on microsatellite instability (MSI), genetic… read more here.
Keywords: ampullary duodenal; non ampullary; molecular features; expression ... See more keywords
Comparative Analysis of Outcomes and Clinicopathological Characteristics of Duodenal Adenocarcinoma: A SEER Analysis
Sign Up to like & getrecommendations! Published in 2020 at "Cancer Investigation"
DOI: 10.1080/07357907.2020.1824260
Abstract: Abstract Duodenal adenocarcinoma is an uncommon, malignant tumor usually accompanied by a poor prognosis. We identified 3150 duodenal adenocarcinoma cases from the SEER database (1988–2013) to analyze clinical characteristics and outcomes. The Kaplan–Meier method was… read more here.
Keywords: comparative analysis; outcomes clinicopathological; analysis; analysis outcomes ... See more keywords
Duodenal adenocarcinoma: neoadjuvant and adjuvant therapy strategies
Sign Up to like & getrecommendations! Published in 2019 at "Expert Opinion on Orphan Drugs"
DOI: 10.1080/21678707.2019.1684257
Abstract: ABSTRACT Introduction: Duodenal adenocarcinoma (DA) is a relatively rare gastrointestinal malignancy associated with poor outcomes. The mainstay of treatment is surgical resection with regional lymphadenectomy but recurrence rates remain high. Due to the relatively low… read more here.
Keywords: neoadjuvant adjuvant; adenocarcinoma neoadjuvant; therapy; adjuvant therapy ... See more keywords
Prognostic factors of non-ampullary duodenal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Japanese Journal of Clinical Oncology"
DOI: 10.1093/jjco/hyy086
Abstract: Background Non-ampullary duodenal adenocarcinoma, excluding carcinoma in the ampulla of Vater, is a rare disease. Although several prognostic factors have been reported, they remain controversial due to the rarity of non-ampullary duodenal adenocarcinoma. The aims… read more here.
Keywords: chemotherapy; ampullary duodenal; prognostic factors; non ampullary ... See more keywords
Node negative duodenal adenocarcinoma is associated with long-term patient survival following pancreaticoduodenal resection.
Sign Up to like & getrecommendations! Published in 2022 at "ANZ journal of surgery"
DOI: 10.1111/ans.17694
Abstract: BACKGROUND Duodenal adenocarcinoma (DA) is a rare gastrointestinal malignancy. There is limited data reporting patient outcomes following radical pancreatic resection for DA. We assessed the disease-free (DFS) and overall survival (OS) in patients undergoing pancreaticoduodenectomy… read more here.
Keywords: duodenal adenocarcinoma; node negative; resection; pancreatic resection ... See more keywords
Risk Factors for Non-Ampullary Duodenal Adenocarcinoma: A Systematic Review.
Sign Up to like & getrecommendations! Published in 2021 at "Digestive diseases"
DOI: 10.1159/000516561
Abstract: Introduction: An increase in the incidence of duodenal adenocarcinoma has been recently reported. However, little is known about the risk factors for duodenal adenocarcinoma, which are important for screening purposes. We, therefore, aimed to conduct… read more here.
Keywords: risk; ampullary duodenal; non ampullary; risk factors ... See more keywords
Personalized treatment based on mini patient-derived xenografts and WES/RNA sequencing in a patient with metastatic duodenal adenocarcinoma
Sign Up to like & getrecommendations! Published in 2018 at "Cancer Communications"
DOI: 10.1186/s40880-018-0323-y
Abstract: BackgroundTreatment guidelines for a variety of cancers have been increasingly used in clinical practice, and have resulted in major improvement in patient outcomes. However, recommended regimens (even first-line treatments) are clearly not ideal for every… read more here.
Keywords: wes rna; treatment; metastatic duodenal; rna sequencing ... See more keywords
Importance of carbohydrate antigen (CA 19-9) and carcinoembrionic antigen (CEA) in the prognosis of patients with duodenal adenocarcinoma: a retrospective single-institution cohort study.
Sign Up to like & getrecommendations! Published in 2023 at "Oncotarget"
DOI: 10.18632/oncotarget.28406
Abstract: Background: Duodenal adenocarcinoma (DA) is a rare malignancy without validated tumor markers. In practice, carcinoembryonic antigen (CEA) and carbohydrate antigen (CA 19-9) are often used in the management of DA, though their prognostic value is… read more here.
Keywords: antigen cea; duodenal adenocarcinoma; single institution; carbohydrate antigen ... See more keywords
Helical tomotherapy for duodenal adenocarcinoma in an elderly patient: A case report
Sign Up to like & getrecommendations! Published in 2017 at "World Journal of Gastrointestinal Oncology"
DOI: 10.4251/wjgo.v9.i2.94
Abstract: To evaluate the efficacy and feasibility of external beam radiotherapy (EBRT) for duodenal adenocarcinoma in an 84-year-old female who underwent EBRT (2.2 Gy/d for a total dose of 46.2 Gy) using helical tomotherapy (HT). Toxicity… read more here.
Keywords: tomotherapy duodenal; adenocarcinoma; helical tomotherapy; duodenal adenocarcinoma ... See more keywords